Evidence map›Paper›PMID 26941864›Full record

ArticleNuclear medicine and molecular imaging2016

FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis.

Axel Van Der Gucht, Mehdi Aoun-Sebaiti, Paul Kauv, Eric Guedj, Jessie Aouizerate, Antoine Verger, Romain K Gherardi, Anne-Catherine Bachoud-Levi, François-Jérôme Authier, Emmanuel Itti

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Axel Van Der GuchtDepartment of Nuclear Medicine, Hôpital Henri Mondor AP-HP, Paris-Est University, 51 Ave. du Mal de Lattre de Tassigny, F-94010 Créteil, France.
Mehdi Aoun-SebaitiDeparment of Neurology, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris/Paris-Est University, Créteil, F-94010 France.
Paul KauvDepartment of Radiology, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris/Paris-Est University, Créteil, F-94010 France.
Eric GuedjDepartment of Nuclear Medicine, Hospital "La Timone", Assistance Publique des Hôpitaux de Marseille, Marseille, F-13000 France.
Jessie AouizerateDepartment of Pathology, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris/Paris-Est University, Créteil, F-94010 France ; Reference Center for Neuromuscular Disorders, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, F-94010 France ; INSERM U955-Team 10, Créteil, F-94010 France.
Antoine VergerCHU Nancy, Nuclear Medecine & Nancyclotep Experimental Imaging Platform, Nancy, F-54000 France.
Romain K GherardiDepartment of Pathology, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris/Paris-Est University, Créteil, F-94010 France ; Reference Center for Neuromuscular Disorders, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, F-94010 France ; INSERM U955-Team 10, Créteil, F-94010 France.
Anne-Catherine Bachoud-LeviDeparment of Neurology, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris/Paris-Est University, Créteil, F-94010 France ; INSERM U955-Team 1, Créteil, F-94010 France.
François-Jérôme AuthierDepartment of Pathology, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris/Paris-Est University, Créteil, F-94010 France ; Reference Center for Neuromuscular Disorders, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, F-94010 France ; INSERM U955-Team 10, Créteil, F-94010 France.
Emmanuel IttiDepartment of Nuclear Medicine, Hôpital Henri Mondor AP-HP, Paris-Est University, 51 Ave. du Mal de Lattre de Tassigny, F-94010 Créteil, France.
Centre Hospitalier Universitaire Henri-Mondor · FRInstitut Mondor de Recherche Biomédicale · FRUniversité Paris-Est Créteil · FRImagerie Adaptative Diagnostique et Interventionnelle · FRInstitut de Médecine Tropicale du Service de Santé des Armées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain Positron Emission Tomography/Computed Tomography with (18)F-fluorodeoxyglucose (FDG PET/CT) was performed in a 44-year-old woman with marked cognitive impairment, diffuse myalgias, sensory, memory and visual disorders, and chronic fatigue, presenting with histopathological features of macrophagic myofasciitis (MMF) at deltoid muscle biopsy. Cerebromedullary Magnetic Resonance Imaging (MRI), electromyography, ophthalmic examination, and cerebrospinal fluid analysis were normal. Visual analysis of FDG PET/CT images showed an atypical pattern of hypometabolism, involving symmetrically the occipital cortex, temporal lobes, and limbic system (including in particular amygdalo-hippocampal complexes), and the cerebellum. Posterior cingulate cortex and parietal areas were preserved. This pattern was confirmed by a voxel-based procedure using Statistical Parametric Mapping (SPM12) that compared a patient's images to normal reference samples from six healthy subjects with adjustment to age obtained using the same PET/CT camera. These results provide a glucose metabolism substrate for cognitive complaints in patients with long-lasting aluminium hydroxide-induced MMF.

Indexed as

18F-FDGAluminum hydroxideBrain imagingMacrophagic myofasciitis

Identifiers

PMID26941864
PMCPMC4762870
OpenAlexW1592078603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.